Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors. [electronic resource]
Producer: 20190927Description: 1277-1286 p. digitalISSN:- 1179-1950
- Antineoplastic Agents -- therapeutic use
- Blood-Brain Barrier -- metabolism
- Carcinoma, Non-Small-Cell Lung -- diagnosis
- Crizotinib -- analogs & derivatives
- Drug Resistance, Neoplasm
- Gene Rearrangement
- Humans
- Lung Neoplasms -- diagnosis
- Molecular Targeted Therapy
- Mutation
- Permeability
- Protein Kinase Inhibitors -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.